NASDAQ:BBI
Delisted
Brickell Biotech Inc. Stock News
$1.94
+0 (+0%)
At Close: Feb 07, 2023
Brickell Biotech Announces Settlement of Dispute with Bodor Labs and Entry into Equity Funding Agreements
11:30am, Tuesday, 18'th Feb 2020
Brickell Biotech, Inc. and its subsidiary (collectively, “Brickell”) (BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics fo
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 13.) Anavex Life Sciences Corp (NASDAQ: AVXL
The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO
01:05pm, Thursday, 13'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 12) AbbVie Inc (NYSE: ABBV ) Agile Therapeutics Inc (N
The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data
02:18pm, Wednesday, 12'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 11) AbbVie Inc (NYSE: ABBV ) Acceleron Pharma Inc (NAS
DDD, NVTA among premarket gainers
02:27pm, Monday, 13'th Jan 2020
Adaptimmune Therapeutics PLC (NASDAQ:ADAP) +56% as SPEAR T-cell platform delivers initial responses in four solid tumors.Verona Pharma PLC (NASDAQ:VRNA) +54% on positive ensifentrine data.Mereo BioP
Brickell Biotech, Inc. (“Brickell”) (BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating s
Brickell Bio Announces Third Quarter 2019 Financial Results and Provides Corporate Update
09:05pm, Wednesday, 13'th Nov 2019
BOULDER, Colo., Nov. 13, 2019 -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated.
Brickell Biotech Provides Update on Bodor Labs Complaint and Funding Agreement with NovaQuest
08:42pm, Wednesday, 30'th Oct 2019
Brickell Biotech, Inc. (“Brickell”) (NASDAQ: BBI), a clinical-stage pharmaceutical company, today announced that it has initiated an arbitration proceeding pursuant to Article 9 of the License Agr
Brickell Biotech Completes Merger with Vical
10:45am, Tuesday, 03'rd Sep 2019
Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company, today announced the completion of its merger with Vical Incorporated (“Vical”), following approval b
Bitbond Closes BaFin Approved Security Token Offering: Investors from 87 Different Countries Participated
11:48am, Tuesday, 09'th Jul 2019
Bitbond's security token offering (STO) closed yesterday raising over €2.1 million. The Bitbond Token was the first issuer to receive approval of a prosp
Welcome to Miami: 3H Group plans new hotel after $10.25 million site purchase [Infographic]
07:00am, Wednesday, 13'th Feb 2019
3H Group shells out $10.25 million for the Brickell development site, where a Residence Inn by Marriott was being planned
Hyatt Centric on a roll in 2017 and beyond
12:00am, Tuesday, 11'th Apr 2017
Hyatt's Centric brand set to expand significantly over the next few years
